Abstract:Abstract Background: Cytological examination of body effusion has an essential role in different tumor staging and research of malignancy. Objectives: It is to study the diagnostic effect of serum tumor markers in differentiation between benign and malignant pleural effusion. Materials and Methods: A retrospective research was done on 39 patients (28 male and 11 female with an age range of 50–77 years old). All samples undergo diagnostic thoracocentesis. The cutoff values of serum tumor markers (CEA < 5 ng/mL; CA125 <35 U/mL; CA19-9 < 37 U/mL; and CA15-3 < 31 U/mL). Results: Thirty-nine cases, resulting in 26 (67%) benign pleural effusions and 13 (33%) malignant pleural effusions, mean ± SD of age was higher malignant pleural effusion than benign type. The sensitivity of cytology was 33%. Malignant pleural effusion tended to have higher serum marker tumor concentrations. A comparison association between benign and malignant pleural effusion revealed statistically significant only in CEA. Most areas under the curve had moderate values that ranged between 0.6 for CA125, CA15.3, and other combined tumor markers, except for CEA, which had a good AUC (0.799). The best efficacy of a single tumor marker is CEA with a cutoff value of 2.05 ng/mL; at this cutoff value, the sensitivity, specificity, and accuracy were 69.2%, 88.5%, and 82.1%, respectively. Conclusion: Single serum tumor markers showed moderate sensitivity and low specificity; their combination does not result in to increase level of sensitivity and specificity to a good and dependent level for diagnosis of the malignant pleural effusion. Cytology and serum tumor markers have aided role in diagnosis. Thoracoscopy and pleural biopsy remain dependent diagnostic tools for malignant pleural effusion.

Values of immunocytochemical and quantitative morphometric analyses in cytological differential diagnosis of pleural and peritoneal effusion

Combined Detection of Carcinoembryonic Antigen and C-reactive Protein in Identifying Benign and Malignant Pleural Effusion

The expression levels of VEGF and ICAM-1 in pleural effusion

Significance of Combining Detection of E-cadherin, Carcinoembryonic Antigen,and Calretinin in Cytological Differential Diagnosis of Serous Effusion

Value of Immunohistochemical Detection of Relevant Antibodies in the Exfoliated Cells of Pleural Effusion in the Differential Diagnosis of Malignant Pleural Mesothelioma and Metastatic Pulmonary Adenocarcinoma

Analyses of Malignant Cell of Pleural Effusion,Ascites and Pericardial Effusion

Determination of Ki-67 Expression and Its Significance in Cell Smears of Pleural Effusion and Ascites using Thin-layer Cytology Test

Clinical Significance of Combined Detection of CEA, CYFRA21-1,CA19-9 and Fer in Differential Diagnosis of Benign Pleural Effusion and Malignant Pleural Effusion

Clinical Significance of CK19-2G2,CK18-3A9 and mesothelin assay in diagnosis of pleural effusion

Combined Assays of Tumor Marker CEA, CA153, SCC and CY211 for Differential Diagnosis of Pleural Effusion

The values of E-cadherin and cairetinin immunocytochemistry in differentiat-ing benign and malignant pleural fluids

Cytomorphological Analyses of 2240 Samples of Pleural Effusion,ascites and Pericardial Effusion

The diagnostic value of measure of VEGF、sFas and CEA in the patients with pleural effusion

The Diagnostic Value of Combined Detection of C-erbB-2 and CEA in Chest Fluid to Lung Cancer

Immunohistochemical detection and molecular pathological examination of 142 cases of malignant pleural effusion

Diagnostic Accuracy of Cancer in Pleural Effusion: A Combination Serum Tumor Markers and Cytology

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Combined Detection of CYFRA21-1 and Β2-Mg for Differentiation of Malignant Pleural Effusions

Application of Three Tumor Markers United Detection in Differentiating Benign and Malignant Pleural Effusion

Application value of combined detection of exfoliative cytology,DNA heteroploid analysis and serum tumor marker in malignant pleural/ascitic fluid

Cytological Differential Diagnosis among Adenocarcinoma, Epithelial Mesothelioma, and Reactive Mesothelial Cells in Serous Effusions by Immunocytochemistry